Abstract:The consortium of microbes inhabiting the human body, together with their encoded genes and secreted metabolites, is referred to as the “human microbiome.” Several studies have established a link between the composition of the microbiome and its impact on human health. This impact spans local gastrointestinal inflammation to systemic autoimmune disorders and neurodegenerative diseases such as Alzheimer’s and Autism. Some of these links have been validated by rigorous experiments that identify specific strains as mediators or drivers of a particular condition. Consequently, the development of probiotics to compensate for a missing beneficial microbe(s) has advanced and become popular, especially in the treatment of irritable bowel diseases and to restore disrupted gut flora after antibiotic administration. The widespread use of probiotics is often advocated as a natural ecological therapy. However, this perception is not always accurate, as there is a potential for unexpected interactions when administering live microbial cultures. Here, we designed this research to explore the intricate interactions among probiotics, the host, and microbes through a series of experiments. Our objectives included assessing their immunomodulatory effects, response to oral medications, impact on microbial population dynamics, and mediation of antibiotic resistance. To achieve these goals, we employed diverse experimental protocols, including cell-based enzyme -linked immunosorbent assay (ELISA), antibiotic susceptibility testing, antimicrobial activity assays, computational prediction of probiotic genes responsible for antibiotic resistance, polymerase chain reaction (PCR)-based validation of predicted genes, and survival assays of probiotics in the presence of selected oral medications. Our findings highlight that more than half of the tested probiotics trigger an inflammatory response in the Caco-2 cell line, are influenced by oral medications, exhibit antibacterial activity, and possess genes encoding antimicrobial resistance. These results underscore the necessity for a reevaluation of probiotic usage and emphasize the importance of establishing regulations to govern probiotic testing, approval, and administration.

Probiotics as an alternative antimicrobial therapy: Current reality and future directions

Probiotics interaction with foodborne pathogens: a potential alternative to antibiotics and future challenges

The Potential Impact of Probiotics on Human Health: An Update on Their Health-Promoting Properties

Using probiotics in clinical practice: Where are we now? A review of existing meta-analyses

Immunomodulatory Activity of Probiotics in Models of Bacterial Infections

Probiotics and gastrointestinal disease: successes, problems and future prospects

Postbiotics: An overview of concepts, inactivation technologies, health effects, and driver trends

Probiotic agents and infectious diseases: a modern perspective on a traditional therapy

Mechanisms of medicinal, pharmaceutical, and immunomodulatory action of probiotics bacteria and their secondary metabolites against disease management: an overview

Probiotics: an alternative anti-parasite therapy

Postbiotic as Novel Alternative Agent or Adjuvant for the Common Antibiotic Utilized in the Food Industry

Probiotics Modulate Host Immune Response and Interact with the Gut Microbiota: Shaping Their Composition and Mediating Antibiotic Resistance

The Use of Probiotics for Management and Improvement of Reproductive Eubiosis and Function

Probiotics: Isolated bacteria strain or mixtures of different strains? Two different approaches in the use of probiotics as therapeutics

Next-generation probiotics: the upcoming biotherapeutics

Biotechnological Applications of Probiotics: A Multifarious Weapon to Disease and Metabolic Abnormality

Probiotics in Orthopedics: From Preclinical Studies to Current Applications and Future Perspective

Probiotics for Human and Poultry Use in the Control of Gastrointestinal Disease: A Review of Real-World Experiences

Exploring Therapeutic Advances: A Comprehensive Review of Intestinal Microbiota Modulators

Probiotics: Versatile Bioactive Components in Promoting Human Health

Future Modulation of Gut Microbiota: From Eubiotics to FMT, Engineered Bacteria, and Phage Therapy